Recruitment and eligibility in a Phase 1 early Alzheimer's disease trial of Sabirnetug
Site databases recruited the most screened and enrolled participants.Diverse participants were primarily recruited from site databases.The diversity of enrolled participants was lower than screened participants.More ineligible participants were from diverse racial and ethnic groups.No approach was observed to be a one-size-fits-all method to recruit and enroll a diverse pool of participants.
Authors
- Todd Feaster
- Vladimir Skljarevski
- Eric Siemers
- Alyssa N. Carroll
- Karen Sundell
- Gopalan Sethuraman
- Siew Tin Gan
- Robyn Moxon
- Janice M. Hitchcock
Institutions
- Acumen Pharmaceuticals (United States) (US)
Publication Details
- Journal
- Alzheimer s & Dementia Translational Research & Clinical Interventions
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1002/trc2.70161
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00